• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱肿瘤经尿道切除术后上尿路尿路上皮肿瘤

Upper tract urothelial tumor after transurethral resection for bladder tumor.

作者信息

Palou J, Fariña L A, Villavicencio H, Vicente J

机构信息

Instituto de Urología, Nefrología y Andrología, Fundación Puigvert, Barcelona, Spain.

出版信息

Eur Urol. 1992;21(2):110-4. doi: 10.1159/000474814.

DOI:10.1159/000474814
PMID:1499609
Abstract

We present a retrospective review of 30 patients who developed upper urinary tract tumors (UUTT) after having been diagnosed and treated for a bladder neoplasm. The mean patient age was 63 years (range 54-72). An average of 4.8 (range 1-10) transurethral resections (TUR) had been performed for bladder cancer prior to the appearance of UUTT. The length of time elapsed between the initial bladder TUR and the subsequent diagnosis of UUTT was variable, with increased incidence in the first 24-72 months (63.3% of the cases). In 21 cases (70%) the bladder tumor was multiple and in 28 (93.3%) the tumor was recurrent. In those patients with unilateral vesicoureteral reflux, an increased incidence of UUTT was found in the refluxing renal unit. In patients with poorly differentiated (grade 3 and grade 2-3) bladder tumors, UUTT was of the similar grade of anaplasia in 75% of cases. These observations, together with those previously published in the literature, allow us to recommend the use of excretory urography (IVP) every 2 years during the first 6 years of follow-up in patients treated for recurrent and/or multiple bladder tumor. Thereafter, follow-up would depend upon the individual clinical situation.

摘要

我们对30例在诊断和治疗膀胱肿瘤后发生上尿路肿瘤(UUTT)的患者进行了回顾性研究。患者的平均年龄为63岁(范围54 - 72岁)。在UUTT出现之前,平均已针对膀胱癌进行了4.8次(范围1 - 10次)经尿道切除术(TUR)。从最初的膀胱TUR到随后诊断出UUTT之间的时间间隔各不相同,在前24 - 72个月发病率增加(占病例的63.3%)。21例(70%)膀胱肿瘤为多发性,28例(93.3%)肿瘤复发。在那些有单侧膀胱输尿管反流的患者中,反流的肾单位中UUTT的发病率增加。在低分化(3级和2 - 3级)膀胱肿瘤患者中,75%的病例UUTT的间变程度相似。这些观察结果,连同先前文献中发表的那些结果,使我们建议在复发性和/或多发性膀胱肿瘤患者的随访的前6年中,每2年进行一次排泄性尿路造影(IVP)。此后,随访将取决于个体临床情况。

相似文献

1
Upper tract urothelial tumor after transurethral resection for bladder tumor.膀胱肿瘤经尿道切除术后上尿路尿路上皮肿瘤
Eur Urol. 1992;21(2):110-4. doi: 10.1159/000474814.
2
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.同步原发性浅表性膀胱癌和上尿路肿瘤临床参数的多变量分析
J Urol. 2005 Sep;174(3):859-61; discussion 861. doi: 10.1097/01.ju.0000169424.79702.6d.
3
[Upper urinary tract tumors following bladder cancer].[膀胱癌继发上尿路肿瘤]
Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1362-6. doi: 10.5980/jpnjurol1989.81.1362.
4
Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings.膀胱癌继发肾盂及输尿管癌:发生率、危险因素及临床病理特征
J Urol. 1989 Jun;141(6):1311-3. doi: 10.1016/s0022-5347(17)41291-2.
5
Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma.复发性浅表性膀胱癌经尿道切除术后的膀胱输尿管反流及上尿路移行细胞癌
J Urol. 1987 Jul;138(1):49-51. doi: 10.1016/s0022-5347(17)42984-3.
6
Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients.表浅性膀胱癌治疗后发生的上尿路肿瘤:591例连续患者的7年随访
Urology. 1999 Jun;53(6):1144-8. doi: 10.1016/s0090-4295(99)00002-3.
7
Upper tract transitional cell carcinoma following cystectomy for bladder cancer.膀胱癌膀胱切除术后的上尿路移行细胞癌
Eur Urol. 2001 Sep;40(3):318-23. doi: 10.1159/000049793.
8
Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence.膀胱切除术前支架置入是上尿路复发的独立危险因素。
J Urol. 2017 Dec;198(6):1263-1268. doi: 10.1016/j.juro.2017.06.020. Epub 2017 Jun 8.
9
[Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].膀胱癌根治性膀胱切除术后上尿路移行细胞癌4例
Hinyokika Kiyo. 1988 Sep;34(9):1593-9.
10
Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma.原发性膀胱移行细胞癌治疗后上尿路尿路上皮肿瘤
Urology. 1992 Dec;40(6):509-11. doi: 10.1016/0090-4295(92)90404-k.

引用本文的文献

1
Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history.尿 pH 值是有吸烟史的非肌层浸润性膀胱癌患者上尿路复发的独立预测因子。
Sci Rep. 2021 Oct 19;11(1):20675. doi: 10.1038/s41598-021-00184-y.
2
Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis.混合回肠袋与抗反流和反流性输尿-回肠吻合术。
BMC Urol. 2021 Jun 11;21(1):92. doi: 10.1186/s12894-021-00828-1.
3
Which is better in patients with hydronephrosis before radical cystectomy-percutaneous nephrostomy versus internal ureteral stents.
在根治性膀胱切除术前行经皮肾造瘘术与输尿管内支架置入术,哪种方法对肾积水患者更有效。
Transl Androl Urol. 2017 Dec;6(6):1195-1197. doi: 10.21037/tau.2017.10.08.
4
Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?对于接受卡介苗膀胱内免疫治疗的原发性膀胱T1G3尿路上皮癌患者,是否有可能停止随访?
World J Urol. 2017 Feb;35(2):237-243. doi: 10.1007/s00345-016-1856-9. Epub 2016 Jun 9.
5
Monitoring of the upper urinary tract in patients with bladder cancer.膀胱癌患者上尿路的监测
Indian J Urol. 2011 Apr;27(2):238-44. doi: 10.4103/0970-1591.82844.
6
Development and progression of urothelial carcinoma.尿路上皮癌的发生与进展。
Cancer Sci. 2006 Sep;97(9):821-8. doi: 10.1111/j.1349-7006.2006.00264.x. Epub 2006 Jul 4.